1. Home
  2. ONDS vs KYTX Comparison

ONDS vs KYTX Comparison

Compare ONDS & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONDS
  • KYTX
  • Stock Information
  • Founded
  • ONDS 2014
  • KYTX 2018
  • Country
  • ONDS United States
  • KYTX United States
  • Employees
  • ONDS N/A
  • KYTX N/A
  • Industry
  • ONDS Telecommunications Equipment
  • KYTX
  • Sector
  • ONDS Telecommunications
  • KYTX
  • Exchange
  • ONDS Nasdaq
  • KYTX NYSE
  • Market Cap
  • ONDS 102.0M
  • KYTX 92.1M
  • IPO Year
  • ONDS N/A
  • KYTX 2024
  • Fundamental
  • Price
  • ONDS $1.22
  • KYTX $2.55
  • Analyst Decision
  • ONDS Strong Buy
  • KYTX Strong Buy
  • Analyst Count
  • ONDS 2
  • KYTX 5
  • Target Price
  • ONDS $3.25
  • KYTX $19.00
  • AVG Volume (30 Days)
  • ONDS 7.6M
  • KYTX 382.4K
  • Earning Date
  • ONDS 05-15-2025
  • KYTX 05-13-2025
  • Dividend Yield
  • ONDS N/A
  • KYTX N/A
  • EPS Growth
  • ONDS N/A
  • KYTX N/A
  • EPS
  • ONDS N/A
  • KYTX N/A
  • Revenue
  • ONDS $10,815,867.00
  • KYTX N/A
  • Revenue This Year
  • ONDS $256.61
  • KYTX N/A
  • Revenue Next Year
  • ONDS $104.92
  • KYTX N/A
  • P/E Ratio
  • ONDS N/A
  • KYTX N/A
  • Revenue Growth
  • ONDS N/A
  • KYTX N/A
  • 52 Week Low
  • ONDS $0.54
  • KYTX $1.78
  • 52 Week High
  • ONDS $3.40
  • KYTX $16.64
  • Technical
  • Relative Strength Index (RSI)
  • ONDS 72.31
  • KYTX 57.07
  • Support Level
  • ONDS $0.83
  • KYTX $2.43
  • Resistance Level
  • ONDS $1.15
  • KYTX $2.82
  • Average True Range (ATR)
  • ONDS 0.11
  • KYTX 0.23
  • MACD
  • ONDS 0.04
  • KYTX 0.04
  • Stochastic Oscillator
  • ONDS 97.87
  • KYTX 64.47

About ONDS Ondas Holdings Inc.

Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

Share on Social Networks: